Immune system breakthrough gives hope to IVFHerald SunIf high, he will prescribe a low dose of steroid prednisolone and blood-thinning medicine clexane. "We know these medications are safe and that they work. They are also cheap and available,&quo…
Doctors prescribing needless steroids for chest infections6minutesTens of thousands of Australians are being inappropriately prescribed inhaled corticosteroids (ICS), putting their health at risk and costing the federal government millions of dollars a…
CHOP experts describe research in pediatric heart diseaseScience CodexWhile calcineurin inhibitors (CNIs) have been the cornerstone of immunosuppression in heart transplant patients, CNIs are toxic to the kidneys and are not effective for cardiac allog…
Responsible prescribing for asthma and COPDNursing TimesCorticosteroids in persistent asthma. Inhaled corticosteroids reduce airway inflammation, reduce airway hyper-responsiveness and improve airflow, and consequently can both control the disease proc…
Novartis receives EC approval for treatment of renal angiomyolipomaEquities.comThis approval is based on data from the Phase III EXIST-2 (EXamining everolimus In a Study of TSC) trial, which found that 42% of patients taking everolimus experienced an a…
Patients with aberrations in two genes respond better to drugs blocking a well …Science CodexDr Janku said: "We found that heavily pre-treated patients with PIK3CA mutations, PTEN aberrations, or both had a significantly higher response rate on …
Micell Technologies Announces Issuance of Core Technology PatentSacramento BeeThis intellectual property protection is related to Micell's investigational MiStent® Sirolimus Eluting Absorbable Polymer Coronary Stent System (MiStent SES™), as wel…
European Commission approves Novartis' Votubia to treat renal …pharmabiz.comThe European Commission (EC) has approved Novartis' Votubia (everolimus) tablets for the treatment of adult patients with renal angiomyolipoma associated with tuberou…
Novartis gets another approval for everolimus in EUPharmaTimesSpecifically, the approval for Volubia (everolimus) is for aforementioned patients who are at risk of complications (based on factors such as tumour size or presence of aneurysm) but who do …
Novartis drug VotubiaR approved in the EU as first medication to treat …ReutersBasel, November 5, 2012 – Novartis received approval from the European Commission (EC) for Votubia R (everolimus) tablets* for the treatment of adult patients with renal a…